MORAb-066
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MORAb-066, covering 2024-03-29 to 2024-03-29. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC [Phase 1]